Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
about
UK guidelines for the management of bone sarcomasFifteen years of irinotecan therapy for pediatric sarcoma: where to next?Children's Oncology Group's 2013 blueprint for research: bone tumorsManagement of Ewing sarcoma family of tumors: Current scenario and unmet needVorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK PathwaysPhase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study.Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma.Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors.Irinotecan and temozolamide treatment for relapsed Ewing sarcoma: a single-center experience and review of the literature.A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors.Chemotherapy in Ewing's sarcoma.Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: a report from the Children's Oncology Group.Current therapeutic approaches in metastatic and recurrent ewing sarcomaInitial testing (stage 1) of temozolomide by the pediatric preclinical testing programPhase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study.Camptothecin-based regimens for treatment of ewing sarcoma: past studies and future directionsTargeting the DNA repair pathway in Ewing sarcomaPrimary paraesophageal Ewing's sarcoma: an uncommon case report and literature review.Chest wall tumors: Diagnosis, treatment and reconstruction.Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours.Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investmentPhase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid tumors.Molecular profiling of childhood cancer: Biomarkers and novel therapiesPrimary hepatic leiomyosarcoma with liver metastasis of rectal cancer.Advances in paediatric cancer treatmentPrimary Ewing Family of Tumors of the Jaw Has a Better Prognosis Compared to Tumors of Extragnathic Sites.Clinical outcomes and prognostic factors of adult's Ewing sarcoma family of tumors: single center experience.A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcomaPreclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable Toxicity.Selecting multimodal therapy for rhabdomyosarcoma.Sarcomas gone bad: what to do about recurrent Ewing sarcoma.A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study.The adolescent and young adult with cancer: state of the art -- bone tumors.Optimal management of Ewing sarcoma family of tumors: recent developments in systemic therapy.The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma.Investigational therapies for Ewing sarcoma: a search without a clear finding.Effect of temozolomide on the viability of musculoskeletal sarcoma cells.Topotecan and cyclophosphamide in adults with relapsed sarcoma.Three-year Follow up of GMCSF/bi-shRNA(furin) DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma.
P2860
Q26752425-8AD7A288-F3AE-4084-9E18-E1C1389A6BF4Q26795742-66CE7C0A-596C-468C-80FF-116B6DF17A6DQ27027664-2710B527-6F5D-4464-99A7-1359AE605867Q28073218-8502E129-42D2-47A2-800B-5C99982DB5B8Q28550980-24DA8D40-1F3E-459E-A8AE-5B93BAB1A3AEQ33387707-19149EA5-1876-40E7-985E-45B6C455C552Q33404428-C2A7CC2E-6AD5-4B95-9C60-F5AC9B28A7C0Q33416097-64F00FA2-252F-4809-8546-B717F5399B48Q33417823-1412E7F1-F5BD-4BC2-BBAD-8206F2823819Q34136875-748A88EB-BC46-4284-A531-461933641286Q34164686-7E65F986-1FFD-41B0-AED2-CE88402AC863Q34281235-E984FD60-F9F2-4820-9B99-6A82C3C89BC1Q34373180-0ECA4F2D-1BEE-4080-936D-C976FAEB3F4FQ34571940-B0C949EC-240D-4D37-9246-A7E4FDDEDE1DQ34679179-3D888FB4-88F6-4160-A61E-AFF867BE726CQ34787772-9059992F-5179-482B-AB8A-6D0037E6271AQ35283099-75C64F36-C31E-455A-B102-1C838CADF071Q35624209-7FA1E2BA-D58B-4A43-9780-7388F2585239Q35753967-63F8812E-B65A-4234-BF3C-26AB1240CDA6Q35957998-8828B1E8-5E29-4C99-AC02-046215D9041BQ35958048-48F7401B-4CA6-4EAF-A23B-D39364A26CDDQ36036684-74CD0BC6-D247-42DF-949D-73269BED3376Q36250783-475ACF73-06B0-48ED-8AC3-BC05B6630D37Q36316741-DE2BA9BE-300D-40E4-85EE-6E0CA4456A06Q36508630-68E888B4-E177-48FE-87A8-3D092B18FE7FQ36849620-59D8EFFB-ABA4-4562-9BAD-990A697D3617Q37048919-819436C6-00A4-48BA-9C5A-82B3DDFD7EA9Q37061813-6AE4FCCA-8EAA-43F4-ADED-B59E9F421916Q37256170-4DF06816-4739-465C-B0BC-3A3A97AB53B0Q37397097-332380B1-E525-4284-B94E-E43FC83015BAQ37782096-1F968AFA-68B2-4ECA-B268-E5646FAC3C9FQ37890995-FFDB411D-B4A8-4EC6-8343-42AF2D9B93A3Q38086448-FC22DEB8-C651-48BE-A64C-F36F123640C6Q38108248-09CD80EA-4C72-45AE-BF8E-3426E4C8C080Q38113988-4800AF55-7C97-4BE5-8DEA-434F03286EC8Q38315670-09766556-8D9E-41A5-A7C0-028B28BEDA0EQ38778855-6D5D1AEB-14AD-494C-A9AC-F01CDDDCAD1CQ40257600-B0DB15F7-F72C-46BC-A639-A4CE11AD5CB8Q40278945-39DEB6D2-37F5-4503-849A-B0389C42B19EQ41093026-FB498B6E-8DD1-4E25-A677-921E6C4A57F7
P2860
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
@ast
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
@en
type
label
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
@ast
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
@en
prefLabel
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
@ast
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
@en
P2093
P50
P356
P1476
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
@en
P2093
Denise A Casey
Leonard H Wexler
Melinda S Merchant
Pamela R Merola
P304
P356
10.1002/PBC.22206
P577
2009-12-01T00:00:00Z